Stem cell transplants from adult donors or umbilical
cord blood, commonly known as bone marrow
transplants, are often the last hope of survival for
patients with blood cancers such as leukaemia.
However, more than 400 patients each year in the UK
are denied access to this potentially lifesaving
treatment because they lack a suitable donor.
NHSBT manages the British Bone Marrow Registry
(BBMR), the NHS Cord Blood Bank (NHS CBB) and
provides specialist services related to the
provision of haematopoietic stem cells (stem cells
which can turn into blood cells) for the treatment
of blood cancers. We aim to continually increase the
quality and effectiveness of our stem cells
Having led the UK Stem Cell
Strategic Forum we are now working with partners
across the sector with the aim of delivering against
the recommendations made for improving provision of
stem cells for transplantation. The NHS CBB already
holds the UK´s largest inventory of donated cord
blood units and we are now working with Anthony
Nolan to build a combined inventory of 50,000 units
with increased genetic diversity to improve outcomes
for all patients needing a stem cell transplant.
UK Stem Cells 'can help British blood cancer patients win the race against time'